Cholesterol Education Program: Hearing Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, First Session, December 7, 1989U.S. Government Printing Office, 1990 - 149 pages Abstract: The hearing reported in this document considered the debate over the role government should play in cholesteral education. The value of the National Heart, Lung, and Blood Institute's massive National Cholesteral Education Program in questioned and the placement of such a high priority on cholesteral education while other national health problems exist is challenged. Two witnesses testify that the hazards of cholesteral have been greatly exaggerated. Methods of cholesteral screening (public screenings vs. private visits to doctors) and their relative merits are discusses. Other witnesses assert that the dangers of cholesteral are not overstated and that the government's role in publicizing cholesteral related information will help to lower suffering and death from chronic heart disease. |
Other editions - View all
Common terms and phrases
Adult Treatment Panel American Heart Association atherosclerosis benefits blood cholesterol levels Blood Institute cardiovascular disease Chairman Cholesterol Education Program cholesterol lowering cholesterol measurements cholesterol reduction cholestyramine clinical trials coronary events coronary heart disease cost death diet or drugs dietary cholesterol drug therapy effects elderly epidemiologic studies evidence follow-up Framingham Heart Study Framingham Study Garber Testimony gemfibrozil Gotto heart attacks heart disease risk high blood cholesterol high cholesterol levels hypercholesterolemia intervention group Ischemic Heart Disease KUSSEROW laboratory LENFANT Lipid Lipid Research Clinics lipoprotein mg/dl middle-aged million MOORE myocardial infarction National Cholesterol Education National Heart NCEP guidelines NHLBI Oslo Study overall mortality patients percent physicians placebo placebo group population PUBLIC CHOLESTEROL SCREENING public health public screening question rates recommended regression risk of coronary risk of heart saturated fat saturated fatty acids serum cholesterol levels smoking STARE Testimony on Cholesterol Wagner WAXMAN WYDEN
Popular passages
Page 110 - Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.
Page 111 - Frick MH, Elo O, Haapa K, et al: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia; safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Page 108 - Mattson FH. Grundy SM. Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.
Page 50 - Institute shall collect, identify, analyze, and disseminate on a timely basis, through publications and other appropriate means, to patients, families of patients, physicians and other health professionals, and the general public, information on research, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases, the maintenance of health to reduce the incidence of such diseases, and on the use of blood and blood products and the management of blood resources.
Page 108 - Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet.
Page 26 - INSPECTOR GENERAL DEPARTMENT OF HEALTH AND HUMAN SERVICES GOOD MORNING, MR. CHAIRMAN AND MEMBERS OF THE SUBCOMMITTEE, I AM RICHARD P.
Page 102 - Brensike JF, Levy RI, Kelsey SF, et al. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II coronary intervention study.
Page 50 - Provides leadership for a national program in diseases of the heart, blood vessels, blood, lungs, and in the use of blood and the management of blood resources.
Page 104 - The differential effect of serum cholesterol, blood pressure and weight on the incidence of myocardial infarction and angina pectoris.
Page 103 - Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl.